IEIL Closes Acquisition of Arysta LifeScience Corporation
Industrial Equity Investments Limited ("IEIL"), an international
investment company located in the Republic of Ireland, announced that
it has completed its acquisition of Arysta LifeScience Corporation,
from funds advised by Olympus Capital Holdings Asia and its
co-investors. The acquisition is the first investment in Japan for
IEIL since it was established in 2005. The Permira Funds own the Irish
company. The enterprise value is approximately JPY 250bn (US$2.4bn).
"Arysta LifeScience has been one of the fastest growing companies
in our sector in the last four years. Permira´s investment is a
testament to the transformation of our company under Olympus ownership
and to our financial strength," said Chris Richards, CEO, Arysta
LifeScience. "With the support of Permira, we are confident of
maintaining and accelerating our growth, both organically and through
strategic acquisitions."
Headquartered in Tokyo, Arysta LifeScience is the world´s tenth
largest agrochemical company. The company markets a portfolio of more
than 150 active ingredients in more than 125 countries with
approximately 2,400 employees. Since its founding in 2001, Arysta
LifeScience has built a reputation as one of the most agile,
high-performance companies in the global agrochemical industry.
"This transaction is a significant achievement, particularly in
the current debt markets when many other leveraged buyout transactions
are not reaching completion," said Alex Emery, principal, Permira
Advisers KK. "The support we have received from the banking community
is a result of the Arysta LifeScience track record of profitable
growth and cash generation, and convincing growth forecasts."
About Arysta LifeScience Corporation
Headquartered in Tokyo, Japan, Arysta LifeScience is the world´s
largest privately held crop protection and life science company with
2007 revenues of JPY136 billion (US$1.2 billion). An entrepreneurial
provider of crop protection and life science products in more than 125
countries worldwide, Arysta LifeScience specializes in marketing and
distribution of respected crop protection brands and life science
products in harmony with the needs of global partners. More
information on the company is available at: www.arystalifescience.com.
About IEIL
Established in 2005, IEIL is a private investment company located
in the Republic of Ireland.
About Permira
Permira is a leading international private equity firm. The
Permira Funds make long-term investments to transform the performance
of businesses, helping management to realise new visions and build
stronger and more sustainable organizations.
The firm´s teams are based in Frankfurt, Guernsey, London,
Luxembourg, Madrid, Milan, New York, Paris, Stockholm, and Tokyo,
advising funds with a total committed capital of approximately EUR22
billion (US$30 billion). Since 1985, the Permira Funds have completed
over 180 private equity transactions.
For more information visit: www.permira.com
About Olympus Capital Holdings Asia
Olympus Capital Holdings Asia is a leading middle market private
equity firm specializing in partnering with Asian shareholders and
management teams to expand their businesses regionally and globally.
Olympus Capital has a network of investment and operating
professionals located in offices in Tokyo, Delhi, Hong Kong, Seoul,
Shanghai and New York. Since its establishment in 1997, Olympus
Capital has invested over $1.2 billion on behalf of funds and
co-investors in more than 25 portfolio companies throughout Asia.
Olympus Capital, one of the early entrants to the Japan private equity
market, completed its first Japanese investments in partnership with a
major Japanese bank and a trading company in 2000, and established its
Tokyo office soon thereafter in 2001. Target industry sectors include
business services, agribusiness, financial services and environmental
services. Recent investments include Quatrro BPO Solutions (India) and
Kyoto Kimono Yuzen (Japan).